Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Sanson

Showing results (71-80 of 100) with videos related to

Pageof 10
Sort By:
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|August 11, 2019
Whole brain radiotherapy with concurrent temozolomide in multifocal and/or multicentric newly diagnosed glioblastomaL Lahmi, A Idbaih, E Rivin Del Campo, et al.
Genomics|May 1, 1991
Parental origin of chromosome 22 loss in sporadic and NF2 neuromasB Fontaine, M Sanson, O Delattre, et al.
Neurology|February 21, 2008
Genetic markers predictive of chemosensitivity and outcome in gliomatosis cerebriG Kaloshi, S Everhard, F Laigle-Donadey, et al.
British Journal of Cancer|December 17, 2003
Correlation between genetic alterations and growth of human malignant glioma xenografted in nude miceP Leuraud, L Taillandier, L Aguirre-Cruz, et al.
Neuropathology and Applied Neurobiology|January 7, 2005
Olig2 expression, GFAP, p53 and 1p loss analysis contribute to glioma subclassificationK Mokhtari, S Paris, L Aguirre-Cruz, et al.
Neurology|October 27, 2010
IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomasC Houillier, X Wang, G Kaloshi, et al.
Neurology|January 14, 2009
alpha-Internexin expression identifies 1p19q codeleted gliomasF Ducray, E Crinière, A Idbaih, et al.
Neurology|January 28, 2009
TP53 codon 72 polymorphism is associated with age at onset of glioblastomaS El Hallani, F Ducray, A Idbaih, et al.
Neurology|November 13, 2009
Supratentorial low-grade gliomas in older patientsG Kaloshi, D Psimaras, K Mokhtari, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 6, 2017
Progestin-associated shift of meningioma mutational landscapeM Peyre, S Gaillard, C de Marcellus, et al.
Pageof 10

Showing results (71-80 of 100) with videos related to

Sort By:
Pageof 10
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|August 11, 2019
Whole brain radiotherapy with concurrent temozolomide in multifocal and/or multicentric newly diagnosed glioblastomaL Lahmi, A Idbaih, E Rivin Del Campo, et al.
Genomics|May 1, 1991
Parental origin of chromosome 22 loss in sporadic and NF2 neuromasB Fontaine, M Sanson, O Delattre, et al.
Neurology|February 21, 2008
Genetic markers predictive of chemosensitivity and outcome in gliomatosis cerebriG Kaloshi, S Everhard, F Laigle-Donadey, et al.
British Journal of Cancer|December 17, 2003
Correlation between genetic alterations and growth of human malignant glioma xenografted in nude miceP Leuraud, L Taillandier, L Aguirre-Cruz, et al.
Neuropathology and Applied Neurobiology|January 7, 2005
Olig2 expression, GFAP, p53 and 1p loss analysis contribute to glioma subclassificationK Mokhtari, S Paris, L Aguirre-Cruz, et al.
Neurology|October 27, 2010
IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomasC Houillier, X Wang, G Kaloshi, et al.
Neurology|January 14, 2009
alpha-Internexin expression identifies 1p19q codeleted gliomasF Ducray, E Crinière, A Idbaih, et al.
Neurology|January 28, 2009
TP53 codon 72 polymorphism is associated with age at onset of glioblastomaS El Hallani, F Ducray, A Idbaih, et al.
Neurology|November 13, 2009
Supratentorial low-grade gliomas in older patientsG Kaloshi, D Psimaras, K Mokhtari, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 6, 2017
Progestin-associated shift of meningioma mutational landscapeM Peyre, S Gaillard, C de Marcellus, et al.
Pageof 10